Bloomberg BNA Study Analyzes the Impact of Recent Supreme Court Decisions That Leave Life Sciences Industry Under Cloud Of Uncertainty

June 25, 2014

Read the full article (PDF) >

San Diego (June 25, 2014) – Bloomberg BNA and law firm Robins, Kaplan, Miller & Ciresi L.L.P., in conjunction with the Biotechnology Industry Organization, today published a study on the impact of recent U.S. Supreme Court decisions affecting the life sciences industry. The report, Stopped at the Threshold: The Practical Impact of the Supreme Court’s Mayo and Myriad Decisions on Biotechnology Patent Practices, explores the impact of Supreme Court decisions handed down in 2012 and 2013 that have made it more difficult for companies in the multibillion dollar global life sciences industry to obtain patents.

©2014. Used with permission from Bloomberg BNA.

Related Publications

Winter 2021
Pro Bono Publico–For The Public Good
Tim Billion, Lindsey Hanson - The Robins Kaplan Spotlight, Vol. 5, No. 4
Winter 2021
The Case for Charitable Giving
Matthew Frerichs - The Robins Kaplan Spotlight, Vol. 5, No. 4
Winter 2021
The Fictional Wealth Disputes That We Took In and Learned From in 2020
Ena Kovacevic - The Robins Kaplan Spotlight, Vol. 5, No. 4
Fourth Quarter
ANDA Approvals
GENERICally Speaking Winter 2021
Back to Top